GENE ONLINE|News &
Opinion
Blog

2021-09-21| In-DepthSpecial

Research Endeavors in Space Biology – Are We Gearing Towards Another Biological Moonshot?

by Ameya Paleja
Share To
When we speak about scientific research about space, it is common to think about experiments in the areas of physics aimed at improving our understanding of our universe. But, apart from those, scientists also ponder about biology and the effect space has on it. According to a Nature report, out of  3000 experiments conducted in space, 1200 have been in the areas of biology and biotechnology. This, by far, surpasses 300 odd experiments done in the field of physical sciences.  Today, we will deep-dive into this space and see how the area will shape our future.

Experiments conducted in space seem to look at the effect of microgravity or low gravity on things such as water droplets or candle flames. These experiments are easy to show and consume for the public at large. In stark contrast, biological experiments are challenging to demonstrate.

Did you know that nanopore sequencing was performed aboard the International Space Station? So far, experiments conducted have studied the human immune system, growth of plants, gene expression, neurological diseases, cancer treatments, and even carbon emissions in the science labs aboard the ISS. Here we attempted to review important highlights in the field and contemplate how could it impact our future.

GO Prime with only $1.49 now

LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top